NanoViricides
NNVC
55 hedge funds and large institutions have $8.85M invested in NanoViricides in 2016 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 5 closing their positions.
2,300% more call options, than puts
Call options by funds: $24K | Put options by funds: $1K
300% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 5
170% more capital invested
Capital invested by funds: $3.27M → $8.85M (+$5.57M)
34% more funds holding
Funds holding: 41 → 55 (+14)
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
0.14% more ownership
Funds ownership: 0.24% → 0.38% (+0.14%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
Cowen Inc
New York
|
+$725K |
| 2 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
+$705K |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$447K |
| 4 |
Renaissance Technologies
New York
|
+$255K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$211K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIP
Stoneridge Investment Partners
Radnor,
Pennsylvania
|
-$108K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$46.6K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$41.6K |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
-$41K |
| 5 |
D.E. Shaw & Co
New York
|
-$36K |
NNVC Hedge Fund Activity: Q1 2016 in Review
55 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q1 2016, worth a combined $8.85M — up 170% from $3.27M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new NNVC positions and 5 closed out — a net gain of 15 holders — while 8 added to existing stakes and 6 trimmed.
The largest buyer was Cowen Inc, opening a new position worth an estimated $725K. The largest seller was Stoneridge Investment Partners, exiting entirely with an estimated $108K sold.
- 55 institutional investors held NanoViricides (NNVC) as of Q1 2016, up from 41 in Q4 2015.
- Funds reported $8.85M of NanoViricides stock for Q1 2016, up 170% quarter-over-quarter.
- 20 funds opened new NanoViricides positions in Q1 2016 and 5 closed out, a net change of +15 holders.
- The largest NanoViricides buyer in Q1 2016 was Cowen Inc, an estimated $725K added.
- The largest NanoViricides seller in Q1 2016 was Stoneridge Investment Partners, an estimated $108K sold.
Based on aggregated 13F filings for Q1 2016.